Levetiracetam-Induced Parkinsonism in a Huntington’s Disease Patient

Kelly L. Sullivan, Theresa A. Zesiewicz, Juan Sanchez-Ramos, Robert A. Hauser

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

The authors present a man with Huntington disease who was treated with levetiracetam (Keppra) in an effort to reduce chorea. Chorea was markedly reduced, but the patient developed parkinsonism and lethargy after 6 weeks of treatment. Symptoms consisted of resting tremor, rigidity, increased dystonia, and gait difficulty. Side effects from levetiracetam resolved completely within 7 days of levetiracetam discontinuation, and chorea returned to baseline.
Original languageAmerican English
JournalClinical Neuropharmacol
Volume28
DOIs
StatePublished - Jul 28 2005

Disciplines

  • Public Health

Keywords

  • Huntington Disease
  • Levetiracetam-Induced Parkinsonism
  • Patient

Fingerprint

Dive into the research topics of 'Levetiracetam-Induced Parkinsonism in a Huntington’s Disease Patient'. Together they form a unique fingerprint.

Cite this